Page 8 - Ohnson Johnson News Today

In this article, we shall cover the top 30 oncology companies in the world. To skip our detailed analysis of the global oncology industry in 2023, go directly and see Top 10 Oncology Companies in the World. According to a report by McKinsey and Company, the economic outlook for the US healthcare industry in 2023 […]

The Food and Drug Administration is warning people to stay away from unapproved sources of ketamine. According to the agency, compounded ketamine is increasingly being sold as a treatment for depression and other mental health issues, despite it not being tested or authorized for such uses. The FDA also says it is continuing to receive reports of people possibly being harmed by these products.

While nothing in life can be considered 100% future-proof when it comes to the world of finance, there are some tried and true investments and money strategies that have stood the test of time. Learn:...

PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST Disclosure of transparency notification Mechelen, Belgium, 3 October 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today, in accordance with Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers of which shares are admitted to trading on a regulated mar...

All 10 manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said Tuesday, even as many of them are currently suing the administration in an effort to halt the process. Many of the companies told The Hill separately ahead of the Oct. 1 deadline that they would participate.…

J&J's therapy combination of antibody treatment Rybrevant and experimental drug lazertinib showed a clinically meaningful improvement in progression-free survival rate in patients. The drugmaker expects the combination to become a first-line treatment for non small-cell lung cancer (NSCLC) patients with a type of mutation in EGFR protein that causes rapid tumor cell growth. A rival treatment combining AstraZeneca's Tagrisso and chemotherapy also recently succeeded in a late-stag...

Medical Technology Ireland is Europe’s second largest and fastest-growing MedTech Exhibition and Conference, reflecting the dynamic medical device sector in Ireland.

The Food and Drug Administration (FDA) ruled Tuesday that a key drug in popular decongestants is ineffective, which one Canadian group of doctors has known for years.

Caesars confirms breach of its loyalty program database; MGM website and operations at many properties remain down. Casino operators Caesars Entertainment and MGM Resorts are working with law enforcement investigators as they continue to grapple with the impact of recent separate cyber attacks.The cybersecurity breaches were reported within days of each other and follow several other high-profile cyber attacks in several industries. These include hacks of a third-party database serving Johnson &...

FRANKFURT (Reuters) -Novartis' generic-drugs unit Sandoz said on Monday it plans to launch a generic version of Johnson & Johnson's anti-inflammatory drug Stelara under a collaboration deal with Samsung Bioepis. For Sandoz, which is due to become an independent company early next month, the transaction means more investment in the growing market of biosimilars, which are lower-cost copies of complex biotech drugs that have lost patent protection.